Effect of Nano-Curcumin in Juvenile Idiopathic Arthritis
Phase 2
- Conditions
- Children with Juvenile Idiopathic Arthritis(JIA).Juvenile arthritis
- Registration Number
- IRCT20191221045837N1
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
All children between 6 and 16 years old referring to Akbar hospital Rheumatology subspecialty clinic who diagnosed suffering JIA according to ACR Guidline1
Obtain patient/patient's parents informed consent
Exclusion Criteria
Children under 6 years old and or teenagers older than 16 years old
Child with a history of underlying diseases including heart, kidney, liver, bile, digestive and or reumatoid ( any kind of reumatoid diseases except JIA) diseases simultaneous
Consuming anticoagulant medicines like warfarin or anti-platelet medicines by patient
Diabetic patients
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method In all patients, the severity of JIA disease will be assessed and recorded at baseline, at the end of the first month and at the end of the third month of treatment using the ACR-Pedi30 Score. The main factors examined in the ACR-Pedi30 Score are: 1- Physician evaluation of the disease activity (PhGA) 2- Evaluation of the patient or parents of the child from their child's health 3- Evaluation of joint function 4- Number of joints involved 5- Number of joints with limitations in Range of motion (ROM) 6- ESR measurement. Timepoint: At baseline, at the end of the first month and the end of the third month of treatment. Method of measurement: 1- Physician evaluation of the disease activity (PhGA) 2- Evaluation of the patient or parents of the child from their child's health 3- Evaluation of joint function 4- Number of joints involved 5- Number of joints with limitations in Range of motion (ROM) 6- ESR measurement.
- Secondary Outcome Measures
Name Time Method